NCT07441395Phase 2Recruiting

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Study sponsor: Corvus Pharmaceuticals, Inc. · CRVS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-06Estimated
Enrollment · participants200Estimated
Source updated2026-03-05Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Primary completion date changed

Before: Aug 2027. After: Jun 2027.

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source